Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of Stress-Activated Kinases in Response to Tacaribe Virus Infection and Its Implications for Viral Replication. | Viruses | 2022 | 36146824 | PubTator, text mining | PubMed |
| Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors. | Viruses | 2022 | 36146786 | PubTator, text mining | PubMed |
| From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms. | Int J Mol Sci | 2022 | 36142787 | PubTator, text mining | PubMed |
| Kozak Similarity Score Algorithm Identifies Alternative Translation Initiation Codons Implicated in Cancers. | Int J Mol Sci | 2022 | 36142475 | PubTator, text mining | PubMed |
| Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals. | Int J Mol Sci | 2022 | 36142450 | PubTator, text mining | PubMed |
| Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes. | J Med Chem | 2022 | 36136092 | PubTator, text mining | PubMed |
| Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant. | Front Immunol | 2022 | 36131928 | PubTator, text mining | PubMed |
| Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer. | Chin Med J (Engl) | 2022 | 36113844 | PubTator, text mining | PubMed |
| The osteogenetic activities of mesenchymal stem cells in response to Mg2+ ions and inflammatory cytokines: a numerical approach using fuzzy logic controllers. | PLoS Comput Biol | 2022 | 36108031 | PubTator, text mining | PubMed |
| Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. | J Hematol Oncol | 2022 | 36104717 | PubTator, text mining | PubMed |
| Autologous Protein Solution processing alters lymphoid and myeloid cell populations and modulates gene expression dependent on cell type. | Arthritis Res Ther | 2022 | 36096945 | PubTator, text mining | PubMed |
| A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia. | J Med Chem | 2022 | 36094045 | PubTator, text mining | PubMed |
| Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53. | Front Mol Biosci | 2022 | 36090037 | PubTator, text mining | PubMed |
| Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy. | NPJ Regen Med | 2022 | 36085325 | PubTator, text mining | PubMed |
| Shafting Misalignment Malfunction Quantitative Diagnosis Based on Speed Signal SVD-HT and CSF-PPSO-ESN Method. | Comput Intell Neurosci | 2022 | 36082355 | PubTator, text mining | PubMed |
| Trifuhalol A Suppresses Allergic Inflammation through Dual Inhibition of TAK1 and MK2 Mediated by IgE and IL-33. | Int J Mol Sci | 2022 | 36077570 | PubTator, text mining | PubMed |
| Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer. | Int J Mol Sci | 2022 | 36077039 | PubTator, text mining | PubMed |
| Substrate spectrum of PPM1D in the cellular response to DNA double-strand breaks. | iScience | 2022 | 36060052 | PubTator, text mining | PubMed |
| Stellera chamaejasme L. extracts in the treatment of glioblastoma cell lines: Biological verification based on a network pharmacology approach. | Front Oncol | 2022 | 36059675 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=24